個股熱度排行 | 2月7日港股收盤
根據uSMART輿情監測數據，7日港股交易時段，市場關注指數最高的5只股票是阿裏巴巴-SW、中國石油股份、比亞迪股份、開拓藥業-B、海爾智家。
2月7日—港股關注排行TOP5
阿裏巴巴-SW
關注度第一爲阿裏巴巴-SW，該股今日收盤下跌4.49%，報於115.00港元。近5個交易日累計下跌1.63%。在消息面和社交媒體方面，輿情以看空爲主。較被市場關注的消息有：
花旗：阿裏擬額外註冊10億份ADS 可能用作員工股權激勵計劃或軟銀減持
阿裏巴巴-SW跌3.99% 擬額外註冊10億份ADS
中國石油股份
關注度第二爲中國石油股份，該股今日收盤上漲3.27%，報於4.10港元。近5個交易日累計上漲4.06%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
高盛發佈港股首選名單：中銀香港、中石油上榜
中國石油股份漲3.27%
比亞迪股份
關注度第三爲比亞迪股份，該股今日收盤上漲1.86%，報於241.40港元。近5個交易日累計下跌1.71%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
A股春節復市紅盤高開 上證半日企3,400點之上 比亞迪揚逾7%
產銷激增逾300%！6000億新能源車“一哥”火了：比亞迪一度漲停
開拓藥業-B
關注度第四爲開拓藥業-B，該股今日收盤上漲25.31%，報於10.00港元。近5個交易日累計上漲7.41%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
開拓藥業急漲35%越20天線 治療脫髮和痤瘡藥於美國I期臨牀試驗完成首例受試者給藥
快訊：開拓藥業大漲34% GT20029治療脫髮和痤瘡的美國I期臨牀試驗完成首例受試者給藥
海爾智家
關注度第五爲海爾智家，該股今日收盤下跌6.62%，報於29.60港元。近5個交易日累計下跌5.58%。在消息面和社交媒體方面，輿情以看空爲主。較被市場關注的消息有：
科指倒跌2.2% 阿裏、金山、閱文及海爾智家回吐4%-7%
恆生科技指數盤跌近2% 海爾智家挫6.62%表現最差
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
